Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

| --- | --- |


		Page
(1)	Financial Statements

	Statements of Consolidated Income for the years ended November 2, 2025, October 27, 2024, and October 29, 2023	47

	Statements of Consolidated Comprehensive Income for the years ended November 2, 2025, October 27, 2024, and October 29, 2023	48

	Consolidated Balance Sheets as of November 2, 2025 and October 27, 2024	49

	Statements of Consolidated Cash Flows for the years ended November 2, 2025, October 27, 2024, and October 29, 2023	50

	Statements of Changes in Consolidated Stockholders’ Equity for the years ended October 29, 2023, October 27, 2024, and November 2, 2025	51

	Notes to Consolidated Financial Statements	52

(2)	Exhibits

	See the “Index to Exhibits” on pages 87 – 89 of this report

	Certain instruments relating to long-term borrowings constituting less than 10% of registrant’s total assets are not filed as exhibits herewith pursuant to Item 601(b)4(iii)(A) of Regulation S-K. The registrant agrees to file copies of such instruments upon request of the Commission.

	Financial Statement Schedules Omitted

	The following schedules for the Company and consolidated subsidiaries are omitted because of the absence of the conditions under which they are required: I, II, III, IV, and V.